Abstract
Epidermolysis bullosa acquisita (EBA) encompasses a wide spectrum of rare diseases with a common genetic origin transmitted in an autosomal recessive fashion. Mild forms of non-inflammatory EBA are characterized by skin lesions and have gained great relevance in the literature. However, resistant inflammatory EBA with widespread mucosal involvement remains a rare entity given its low prevalence. It commonly represents a great burden for the patient s quality of life with most cases being resistant to different therapeutic modalities.We present a case of resistant inflammatory EBA with esophageal strictures that improved after therapy with intravenous immunoglobulin and rituximab.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 124-126 |
| Number of pages | 3 |
| Journal | Oxford Medical Case Reports |
| Volume | 2021 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 1 2021 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
ASJC Scopus subject areas
- Parasitology
- Microbiology
- Infectious Diseases
Fingerprint
Dive into the research topics of 'Epidermolysis bullosa acquisita: An uncommon cause of esophageal stricture'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS